HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Minoru Shiraga Selected Research

Matrix Metalloproteinase Inhibitors

3/2003A third-generation matrix metalloproteinase (MMP) inhibitor (ONO-4817) combined with docetaxel suppresses progression of lung micrometastasis of MMP-expressing tumor cells in nude mice.
10/2002Organ heterogeneity of host-derived matrix metalloproteinase expression and its involvement in multiple-organ metastasis by lung cancer cell lines.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Minoru Shiraga Research Topics

Disease

3Neoplasms (Cancer)
11/2022 - 10/2002
2Lung Neoplasms (Lung Cancer)
11/2022 - 10/2002
2Neoplasm Metastasis (Metastasis)
03/2003 - 10/2002
1Body Weight (Weight, Body)
03/2003
1Neoplasm Micrometastasis
03/2003
1Asthma (Bronchial Asthma)
02/2003
1Inflammation (Inflammations)
02/2003

Drug/Important Bio-Agent (IBA)

2N- hydroxy- 5- ethoxymethyloxy- 2- methyl- 4- (4- phenoxybenzoyl)aminopentanamideIBA
03/2003 - 10/2002
2Matrix Metalloproteinases (MMPs)IBA
03/2003 - 10/2002
2Matrix Metalloproteinase InhibitorsIBA
03/2003 - 10/2002
1mRNA VaccinesIBA
11/2022
1BNT162 VaccineIBA
11/2022
1COVID-19 VaccinesIBA
11/2022
1VaccinesIBA
11/2022
1Cytotoxins (Cytolysins)IBA
11/2022
1Docetaxel (Taxotere)FDA Link
03/2003
1SteroidsIBA
02/2003
1Adrenal Cortex Hormones (Corticosteroids)IBA
02/2003

Therapy/Procedure

2Therapeutics
03/2003 - 02/2003